An isolated monoclonal antibody population comprising: first antibodies and/or antigen binding fragments thereof, wherein the first antibodies and/or antigen binding fragments thereof comprise: (a) a heavy chain variable region comprising: a complementarity determining region 1 comprising or consisting of an amino acid sequence defined by positions 50-54 of SEQ ID NO: 3; a complementarity determining region 2 comprising or consisting of an amino acid sequence defined by positions 69-85 of SEQ ID NO: 3; a complementarity determining region 3 comprising or consisting of an amino acid sequence defined by positions 118-126 of SEQ ID NO: 3; and (b) a light chain variable region comprising: a complementarity determining region 1 comprising or consisting of an amino acid sequence defined by positions 44-54 of SEQ ID NO: 4; a complementarity determining region 2 comprising or consisting of an amino acid sequence defined by positions 70-76 of SEQ ID NO: 4; a complementarity determining region 3 comprising or consisting of an amino acid sequence defined by positions 109-117 of SEQ ID NO: 4; and wherein the antibody population does not contain second antibodies comprising a light chain variable region comprising: a complementarity determining region 1 comprising or consisting of an amino acid sequence defined by positions 48-58 of SEQ ID NO: 6; a complementarity determining region 2 comprising or consisting of an amino acid sequence defined by positions 74-80 of SEQ ID NO: 6; a complementarity determining region 3 comprising or consisting of an amino acid sequence defined by positions 113-121 of SEQ ID NO: 6. first antibodies and/or antigen binding fragments thereof, wherein the first antibodies and/or antigen binding fragments thereof comprise: (a) a heavy chain variable region comprising: a complementarity determining region 1 comprising or consisting of an amino acid sequence defined by positions 50-54 of SEQ ID NO: 3; a complementarity determining region 2 comprising or consisting of an amino acid sequence defined by positions 69-85 of SEQ ID NO: 3; a complementarity determining region 3 comprising or consisting of an amino acid sequence defined by positions 118-126 of SEQ ID NO: 3; and (b) a light chain variable region comprising: a complementarity determining region 1 comprising or consisting of an amino acid sequence defined by positions 44-54 of SEQ ID NO: 4; a complementarity determining region 2 comprising or consisting of an amino acid sequence defined by positions 70-76 of SEQ ID NO: 4; a complementarity determining region 3 comprising or consisting of an amino acid sequence defined by positions 109-117 of SEQ ID NO: 4; (a) a heavy chain variable region comprising: a complementarity determining region 1 comprising or consisting of an amino acid sequence defined by positions 50-54 of SEQ ID NO: 3; a complementarity determining region 2 comprising or consisting of an amino acid sequence defined by positions 69-85 of SEQ ID NO: 3; a complementarity determining region 3 comprising or consisting of an amino acid sequence defined by positions 118-126 of SEQ ID NO: 3; and a complementarity determining region 1 comprising or consisting of an amino acid sequence defined by positions 50-54 of SEQ ID NO: 3; a complementarity determining region 2 comprising or consisting of an amino acid sequence defined by positions 69-85 of SEQ ID NO: 3; a complementarity determining region 3 comprising or consisting of an amino acid sequence defined by positions 118-126 of SEQ ID NO: 3; and (b) a light chain variable region comprising: a complementarity determining region 1 comprising or consisting of an amino acid sequence defined by positions 44-54 of SEQ ID NO: 4; a complementarity determining region 2 comprising or consisting of an amino acid sequence defined by positions 70-76 of SEQ ID NO: 4; a complementarity determining region 3 comprising or consisting of an amino acid sequence defined by positions 109-117 of SEQ ID NO: 4; a complementarity determining region 1 comprising or consisting of an amino acid sequence defined by positions 44-54 of SEQ ID NO: 4; a complementarity determining region 2 comprising or consisting of an amino acid sequence defined by positions 70-76 of SEQ ID NO: 4; a complementarity determining region 3 comprising or consisting of an amino acid sequence defined by positions 109-117 of SEQ ID NO: 4; and wherein the antibody population does not contain second antibodies comprising a light chain variable region comprising: a complementarity determining region 1 comprising or consisting of an amino acid sequence defined by positions 48-58 of SEQ ID NO: 6; a complementarity determining region 2 comprising or consisting of an amino acid sequence defined by positions 74-80 of SEQ ID NO: 6; a complementarity determining region 3 comprising or consisting of an amino acid sequence defined by positions 113-121 of SEQ ID NO: 6. a complementarity determining region 1 comprising or consisting of an amino acid sequence defined by positions 48-58 of SEQ ID NO: 6; a complementarity determining region 2 comprising or consisting of an amino acid sequence defined by positions 74-80 of SEQ ID NO: 6; a complementarity determining region 3 comprising or consisting of an amino acid sequence defined by positions 113-121 of SEQ ID NO: 6.